MedTrace Logo

The Effect of a Single Dose of Lamotrigine on Brain Function in Healthy Volunteers

NCT04396938 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-05-21

No results posted yet for this study

Summary

This study will test whether a single dose of Lamotrigine (300mg) exerts significant effects on emotional processing, cognitive ability and neural activity in healthy volunteers compared to placebo.

Conditions

  • Healthy

Interventions

DRUG

Lamotrigine

Active Drug Capsule

DRUG

Placebos

Placebo Capsule

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Catherine Harmer, PhD · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-11-29
Completion
2019-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396938 on ClinicalTrials.gov